Advancing precision medicine: Prognostic biomarkers for pediatric Crohn’s disease

Crohn’s disease is a chronic, autoimmune inflammatory bowel condition with no available cure, that can present in pediatric patients who may later develop serious complications such as fistulas and fibrostenosis. Prognostic biomarkers to predict such complications would be valuable tools to optimize care for pediatric patients but are currently lacking.

This webinar will describe how a combination of analytically validated, high-throughput proteomics and transcriptomics can be used to identify prognostic markers with a high degree of accuracy in predicting pediatric patients who will develop complications.

Dr. Hurtado-Lorenzo’s presentation will be of interest for anyone working on autoimmune or inflammatory diseases, or who is interested in protein biomarker research and precision medicine.


Presenter: Dr. Andrés Hurtado-Lorenzo

Crohn’s and Colitis Foundation

Other upcoming events

HUPO 2022 Congress

  • Events
  • Cancun International Convention Center | Cancún, MX

San Antonio Breast Cancer Symposium (SABCS) 2022

  • Events
  • Henry B. Gonzalez Convention Center | San Antonio, TX, USA


Biomarker assays

~881 million

Protein data points generated


Publications listed on website

Contact us!